Skip to content
OpenCapital
Get started

OrthoPediatrics KIDS Scoliosis — Net revenue

Other product segments

Trauma and deformity
$43.05M+13.7%
Sports medicine/other
$875K-0.6%

Similar metrics at other companies

Stryker logo
SYKSpine — Net Sales
$2M-98.8%
Stryker logo
SYKOrthopaedics: — Net Sales
$2.81B+0.1%
CONMED logo
CNMDOrthopedic Surgery — Net Sales
$147.66M+6.8%
TFX
TFXSurgical — Net revenues
$106.79M+12.4%
Alphatec Holdings logo
ATECProducts And Services — Revenue (Gross)
$192.11M+13.6%
Enovis logo
ENOVBracing and Support — Net Sales
$114.88M-0.2%

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0×0.0×
Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's scoliosis — net revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's scoliosis — net revenue?
OrthoPediatrics (KIDS) reported scoliosis — net revenue of $15.44M in Q1 2026.
How has OrthoPediatrics's scoliosis — net revenue changed year-over-year?
OrthoPediatrics's scoliosis — net revenue increased by 13.0% year-over-year, from $13.66M to $15.44M.
What is the long-term trend for OrthoPediatrics's scoliosis — net revenue?
Over 4 years (2021 to 2025), OrthoPediatrics's scoliosis — net revenue has grown at a 23.9% compound annual growth rate (CAGR), from $28.05M to $66.05M.
What does scoliosis — net revenue mean?
This metric represents the total net revenue generated from the sale of medical devices and implants specifically designed for pediatric scoliosis treatment. It reflects the market adoption and commercial performance of the company's specialized spinal correction product portfolio. Growth in this segment indicates successful penetration into the pediatric orthopedic spine market and the effectiveness of the company's clinical solutions.